Bloodwork

Blood pressure

The Wall Pressure

3 formulas on this site modulate this pathway.

This is a measurement, and the direction is only true within range: you want it out of the raised band, not as low as possible. Sustained elevation remodels the heart; too low is its own emergency. You want it in range: neither high enough to strain vessels nor low enough to starve tissue.

What this marker reads

Blood pressure — the force of blood against the vessel wall, a master cardiovascular gauge.

What a named body publishes

Each line below is the sentence the issuing body wrote, carried with its own identifier. Nothing here interprets your result — it states what was published, for whom, and by whom.

Systolic blood pressure

“NORMAL blood pressure is less than 120 mm Hg systolic AND less than 80 mm Hg diastolic.”

2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines · Circulation · 2025 DOI 10.1161/CIR.0000000000001356

“ELEVATED blood pressure is 120-129 mm Hg systolic AND less than 80 mm Hg diastolic.”

“STAGE 1 HYPERTENSION is 130-139 mm Hg systolic OR 80-89 mm Hg diastolic.”

“STAGE 2 HYPERTENSION is 140 mm Hg or higher systolic OR 90 mm Hg or higher diastolic.”

Diastolic blood pressure

“NORMAL blood pressure requires a diastolic pressure below 80 mm Hg together with a systolic pressure below 120 mm Hg.”

“ELEVATED blood pressure requires the diastolic pressure to remain below 80 mm Hg while systolic is 120-129 mm Hg; the two conditions are joined by AND.”

“STAGE 1 HYPERTENSION is met by a diastolic pressure of 80-89 mm Hg on its own, because the systolic and diastolic criteria for this stage are joined by OR.”

“STAGE 2 HYPERTENSION is met by a diastolic pressure of 90 mm Hg or higher on its own, because the systolic and diastolic criteria for this stage are joined by OR.”

Your laboratory reads your result against its own assay, and this page does not do that for it. What is above is what a named body published and for whom; what is below is the machinery the marker reads and the formulas witnessed on it.

What moves it

Blood flow (nitric oxide) lowers it.

Endothelial NO tonically lowers blood pressure in humans (Hypertension, DOI 10.1161/01.hyp.0000252425.06216.26) — NO-synthase inhibition raised mean BP by 6 mmHg in intact subjects and by 21 mmHg under autonomic blockade, isolating the endothelial contribution; eNOS-knockout mice run ~20 mmHg higher. Convergent eNOS-derived NO governs vascular tone, and eNOS is protective against hypertension; NO stimulates vasodilation via cGMP in smooth muscle cells. Two distinct output mechanisms, not one: NO acts both through soluble guanylate cyclase / cGMP and through S-NITROSYLATION of reactive protein thiols — an arrow labeled 'NO' collapses two different signaling systems. Localisation changes the output: plasma-membrane-targeted eNOS drives sGC/cGMP signaling more than Golgi-tethered eNOS, so where the enzyme sits alters what it does. The enzyme has preconditions: functional eNOS requires dimerisation, L-arginine substrate and the BH4 cofactor; without BH4 it uncouples and makes superoxide instead of NO (see the Oxidative Stress (ROS) → Endothelial (eNOS) link). And a null result worth carrying: selective endothelial CaMKII inhibition in two transgenic models left systolic and diastolic blood pressure, heart rate, plasma NO and NO-dependent vasodilation unchanged (PMC5653296) — not every proposed upstream regulator of eNOS matters in vivo. doi 10.1161/01.hyp.0000252425.06216.26 · PMC5653296

Training load lowers it.

Physical-activity interventions lower blood pressure in randomized trials — systematic review/meta-analysis across 18 low- and middle-income countries (PMC11293006); mechanisms include improved insulin sensitivity and reduced vascular resistance. (1) Edwards 2023, Br J Sports Med 57(20):1317-1326, doi 10.1136/bjsports-2022-106503 — 270 randomized controlled trials, 15,827 participants. Resting BP fell with every modality (p<0.001): aerobic -4.49/-2.53 mmHg, dynamic resistance -4.55/-3.04, combined -6.04/-2.54, HIIT -4.08/-2.50, and isometric -8.24/-4.00 mmHg. (2) JAHA 2025, doi 10.1161/JAHA.125.044003 — 105 RCTs: combined -12.05 mmHg SBP, HIIT -10.97. (3) Schneider 2023, J Hypertens 41(7):1068-1076 — 37 studies, 1,942 participants: -6.4/-3.7 mmHg. (4) PMC12357484 — isometric -7.31 mmHg SBP at moderate GRADE certainty (DBP only low). (5) A 92-study review in older hypertensives confirming all modalities. The finding that matters here — two measurement methods give different verdicts on the same question: on resting blood pressure, isometric training ranks first by SUCRA and an expert review states it produces reductions greater than current exercise guidelines achieve and possibly comparable to standard antihypertensive monotherapy (Sports Med 2024;54:1459-1497). But on 24-hour ambulatory blood pressure, a 2026 network meta-analysis of 31 trials / 67 arms concludes evidence for dynamic and isometric resistance training remains uncertain, with only aerobic, combined and HIIT showing consistent 24-hour reductions. A cuff reading in a clinic and a 24-hour monitor do not agree about which exercise is best. GRADE certainty is moderate for systolic and low for diastolic. Exercise-versus-exercise superiority remains inconclusive. doi 10.1136/bjsports-2022-106503 · PMC11293006

Lowers blood pressure raises it.

Angiotensin II plays a critical role in both the acute and chronic regulation of blood pressure: it is a potent vasoconstrictor, stimulates adrenal zona glomerulosa to secrete aldosterone, alters renal sodium and water handling, enhances thirst and drives ADH release. Pathological high blood pressure is mediated principally by the AT1 receptor. PMID 10619573

Sympathetic drive raises it.

Tested by denervation, not by association: in salt-fed rats infused with angiotensin II for 14 days, celiac ganglionectomy — which removes sympathetic outflow to the splanchnic veins — increased venous capacitance and prevented the angiotensin II-induced hypertension, with the rise in mean circulatory filling pressure nullified (Circ Heart Fail 2011, 'Sympathetically Mediated Changes in Capacitance'; mechanism reviewed in PMC5586477). Cutting the nerve to the reservoir prevented the pressure rise, which places the venous side upstream of blood pressure rather than downstream of it. Dose-response across severity, which is stronger than a binary association: the SNS is activated in essential hypertension and the magnitude of activation becomes progressively greater from borderline, to mild, to moderate, to severe hypertensive states. Mechanism: NE stimulates renin release via beta-2, drives alpha-1/alpha-2 vasoconstriction raising renal vascular resistance, and modulates NHE3, NCC and ENaC to reduce sodium excretion. Loss-of-function confirms it: central alpha-2 agonists (clonidine, guanabenz, moxonidine) reduce sympathetic nerve activity and raise vagal tone, lowering cardiac output, heart rate, renin release and vascular resistance — and thereby blood pressure. PMC5586477

Sleep lowers it.

Losing a night of sleep raises blood pressure — shown in a blinded, randomized crossover in healthy adults: 82±8 mmHg after normal sleep versus 86±7 after a night awake (p=0.012) (Hypertension 2000;35:1173, PMID 10818083). But not by the mechanism everyone assumes, and the same study is why we do not draw a the Sleep → Sympathetic link: measured directly by microneurography, muscle sympathetic nerve activity fell (28±6 to 22±6 bursts/min, p=0.017), and the authors conclude the pressor response is not mediated by sympathetic vasoconstriction or tachycardia. Reviews of the gold-standard recordings agree that full-night deprivation does not raise, and may lower, tonic sympathetic outflow — shifting the baroreflex set-point instead (PMC10751264). What is raised is sympathetic reactivity to a stressor, and in older adults the MSNA rise appears only in women. PMID 10818083 · PMC10751264

Sodium load raises it.

PMC7190039 — Salt is the most-discussed dietary lever in cardiovascular health. The finding is not that it works. It is how much the answer depends on WHO is asking. One dose-response meta-analysis reports the same 40 mmol/DAY reduction producing: -4.5 mmHg systolic in chronic kidney disease, -2.3 mmHg in hypertension, and -0.3 mmHg in people without hypertension. A fifteen-fold spread, in one analysis, with one intervention. Three tenths of a millimeter is what a normotensive person gets for cutting nearly half a teaspoon of salt a day. The evidence base is enormous: a separate meta-regression covers 133 randomized controlled trials, and an earlier meta-analysis pooled 56 trials across 1,131 hypertensive and 2,374 normotensive subjects. This is not a thin literature; it is a thick one whose central number is conditional. And potassium is the other half nobody mentions — one review calls it the ignored ion in the sodium-potassium-BP relationship. Dose-response meta-analysis shows potassium supplementation lowers BP, particularly in subjects with hypertension, and salt substitutes formulated with reduced sodium chloride and enriched potassium chloride lower both BP and cardiovascular risk. Baseline potassium intake also modifies the sodium dose-response. The node is drawn as sodium load read against potassium for that reason. And the randomized and observational literatures disagree, which this edge states rather than resolves: the trial overview authors write that their findings conflict directly with the pure study, and cohort analyses have reported increased mortality risk associated with low sodium intake. A meta-analysis of 63 trials is titled reduced dietary sodium intake increases heart rate — the pressure number is not the whole cardiovascular story. PMC7190039

Gut barrier lowers it.

The direct evidence is clean: germ-free mice ARE resistant to hypertension, likely due to reduced immune cell activation. Under angiotensin II infusion, germ-free animals showed reduced reactive oxygen species formation in the vasculature, attenuated vascular expression of MCP-1, iNOS and the NADPH oxidase subunit Nox2, and reduced upregulation of RORgamma-t. And colonization of germ-free mice with regular gut microbiota induced T-bet transcription and produced mild endothelial dysfunction — the transfer direction, not just the absence. High salt works partly through this route: high-salt intake alters the microbiome in a fashion that appears to favor blood pressure elevation, with named mechanisms including short-chain fatty acid production, ISOLEVUGLANDIN adducts in the intestinal mucosa, and induction of IL-17A-producing cells by intestinal bacteria. the Dietary Sodium Load → Blood Pressure link was drawn in enumeration 1; part of what it carries may run through here. And now the part worth the whole enumeration. It has been replicated in Dahl salt-sensitive rats and extended by Treg-deficient transfer experiments. It also has a published, flat replication failure: we never observed any angiotensin II resistance of B6.Rag1-knockout mice purchased directly from the Jackson laboratory as early as 2009. They displayed nearly identical blood pressure increases by RADIOTELEMETRY and identical end-organ damage across different angiotensin doses and different salt intakes. Same strain, better instrumentation, no effect. The authors conclude the resistant phenotype depends on the action of yet unidentified nongenetic modifiers in addition to the absence of functional T cells. Put the two findings together and a candidate for those modifiers is sitting right there: if germ-free mice resist hypertension and colonization restores susceptibility, then the vendor’s microbiome is exactly the kind of nongenetic modifier that would make the same knockout behave differently in two laboratories. rodent throughout. Human microbiome-hypertension evidence is not yet strong enough for a drawn link. doi 10.1161/HYPERTENSIONAHA.124.21355

Calm under stress raises it.

A meta-analysis found A 40 percent excess risk of hypertension among those with anxiety disorder, and those with anxiety disorder are more likely to have cvd risk factors, such as hypertension and diabetes. This edge may therefore be partly carried by that route rather than being independent of it — stated rather than assumed away. Observational, and the excess-risk figure is quoted at second hand within a cohort study rather than read from the meta-analysis directly. PMC10377450

Calms inflammation raises it.

NF-kB signaling is named across the cardiovascular-renal-metabolic reviews as a driver of vascular inflammation and endothelial dysfunction, and endothelial dysfunction is the named proximate cause of raised vascular tone. Drawn from the shared cardio-renal-metabolic reviews rather than a hypertension-specific source. The nfkb node reaches bp through endothelial dysfunction, which is itself a drawn edge - so this is partly a shortcut across an existing path and is marked so. doi 10.1038/s41581-026-01066-0 · PMC11725408

Vessel growth signal lowers it.

The pharmacology is the evidence and it is unusually clean: VEGF-pathway inhibitors used in oncology cause hypertension as a class effect - which establishes that VEGF signaling is required to maintain normal vascular tone, and removing it raises pressure. The sign is counterintuitive and deserves care: VEGF supports normal vascular tone (so the edge is drawn as beneficial to bp), and it is the blockade of VEGF that raises pressure. Drawn on the drug-class effect, which is an inference from the inhibitor to the ligand - a negative-evidence argument, and weaker than a direct measurement. doi 10.1038/s41581-026-01066-0 · PMC11725408

What it moves

It raises Supports heart function.

Pressure is the load the muscle rebuilds against: hypertension causes hemodynamic overload and induces gradual structural remodeling — cardiomyocyte hypertrophy thickening the ventricular wall, plus interstitial and perivascular collagen deposition (PMC11219059). The consequence is a stiffer, less compliant ventricle: diastolic dysfunction first, and over time the transition from hypertrophy to heart failure (PMC8110048). Verbatim: “RAAS activation worsens LVH by increasing blood pressure and by directly affecting cardiac myocytes with AT-II and aldosterone”. doi 10.7759/cureus.26642 · PMC11219059

It lowers Cardiac output.

Prolonged stress induced by risk factors, including aging, diabetes, and hypertension, has deleterious effects, triggering alterations in key signal transduction and metabolic pathways and causing pathological hypertrophy, fibrosis, and apoptosis. The initial response induces cardiomyocyte growth and survival, angiogenesis, antioxidant generation, and mitochondrial biogenesis — all good. It is sustained stimulation that turns it. Same pathway, opposite outcome, and duration is the variable. doi 10.1016/j.jacc.2006.07.007 · PMC10932393

It raises Arterial plaque.

Arterial hypertension is named directly among the mechanisms in a review titled for atherosclerosis, hypertension and coronary artery disease together. This link carries the systemic half of that story. PMC5666716

It lowers Heart & blood pressure.

Named across five inflammaging and hallmarks-of-aging reviews as part of the shared mechanism set that links molecular damage to organ decline: nutritional perception dysregulation and inflammatory aging ARE the core key elements linking upstream molecular damage to downstream organ function decline. doi 10.1016/j.molmet.2023.101755 · PMC11233824

It lowers Kidney.

Named across five reviews of the cardiovascular-renal-hepatic-metabolic syndrome as part of the shared mechanism set: ectopic fat accumulation triggered by metabolic reprogramming, oxidative stress and inflammation induced by energy overload, modified lipids, UREMIC toxins, and senescence, as well as insulin resistance pathways activated by pro-inflammatory factors and lipotoxic products, collectively exacerbate simultaneous hepatic and renal injury. doi 10.1038/s41581-026-01066-0 · PMC11725408

It lowers Sexual function.

Named across six reviews of endothelial dysfunction as part of the shared mechanism set: reduced nitric oxide availability, oxidative stress, inflammatory responses, apoptosis of endothelial cells, and the emerging concept of endothelial-mesenchymal transition. doi 10.3390/jcm15041621 · PMID 33923709 · PMC11988752

It raises Nerve protection.

It lowers Strengthens veins.

It lowers Vision.

Why the retina is the most oxidatively stressed tissue in the body, stated directly: the retina is highly susceptible to oxidative damage due to its elevated oxygen consumption, abundant polyunsaturated fatty acids, and continuous exposure to light. Three risk factors that cannot be separated from its function. And the aging failure is specific and double: in the elderly both the mitophagic process and Nrf2 activation ARE impaired, thus causing retinal cell death. The carotenoid case is unusually mechanical: lutein and zeaxanthin ARE selectively taken up by the RPE, preferentially accumulated in the human macula, and transferred to photoreceptors - a targeted delivery route, not a general antioxidant claim. The Eye Disease Case-Control Study found high plasma levels of lutein and zeaxanthin associated with reduced risk of neovascular AMD. By contrast the reviewers say the relationships between dietary and serum levels of the antioxidant vitamins and age-related macular disease ARE less clear - with alpha-tocopherol the exception, convincingly demonstrated. Lipofuscin is itself a photoreactive substance - the waste product becomes a new damage source. doi 10.3390/antiox14101251 · PMID 11033038 · PMC12026614

It raises Hydration & electrolytes.

The one measured finding among them is the periodontal-anemia link: a meta-analysis of sixteen studies on hemoglobin and iron metabolism in periodontitis, whose authors call the association still controversial and ask for larger cohorts. (PMC7005133; doi 10.1152/japplphysiol.00971.2016; PMC12673670). Verbatim: “A central component of the feedback system for long-term control of arterial pressure is the pressure-natriuresis mechanism, whereby increases in renal perfusion pressure lead to decreases in sodium reabsorption and increases in sodium excretion”. doi 10.1152/japplphysiol.00971.2016 · PMC7005133

Formulas that modulate it

Each formula page names this pathway and carries the study behind its claim.

EKG Cardioprotective (Contractile Reserve) →

Interstellar Matcha (Ceremonial Grade) →

Pulsar (Vascular Pressure Regulation) →

Build a combo from your panel

Open the bloodwork builder and select every marker your lab flagged — it covers the most machinery with the fewest formulas.

Share𝕏 X ● Facebook ◉ Reddit ✈ WhatsApp ✉ Email